Please wait...
About This Project
A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.
Recent Lab Notes From This Project

Browse Other Projects on Experiment
Related Projects
An initial exploration of in-situ underwater genetic sequencing
Our goal is to adapt portable genome sequencing technology for high-pressure, underwater environments. Currently...
Sustainable bio-mining of rare Earth elements utilizing microorganism biotechnology
Rare Earth Elements (REE) are highly sought after for their powerful magnetic properties and energy efficient...
Spatially controlling attachment of functional proteins to bacterial cellulose using optogenetics
The bacterium Komagataeibacter rhaeticus has the ability to naturally produce bacterial cellulose (BC) which...